OOIR: Observatory of International Research

Papers

(The TQCC of Endocrine Reviews is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	507
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	290
Endocrine Manifestations and New Developments in Mitochondrial Disease	252
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	229
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	215
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	194
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	193
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	182
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	178
The Molecular Biology of Midgut Neuroendocrine Neoplasms	176
A critical assessment of fasting to promote metabolic health and longevity	145
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	135
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	121
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	107
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	105
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	95
The Biology and Clinical Implications of PCSK7	93
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	88
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	82
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	81
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	80
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	79
Estrogen Receptor Signaling in the Immune System	78
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	71
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	65

New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	64
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	63
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	59
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	59
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	58
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	57
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	57
The Metabolic Role and Therapeutic Potential of the Microbiome	56
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	55
Imaging of Pheochromocytomas and Paragangliomas	55
Adiponectin and Adiponectin Receptors in Atherosclerosis	54
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	49
The Cortisol Awakening Response: Regulation and Functional Significance	46
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	46
Brown Adipose Tissue—A Translational Perspective	46